Biography
Areas of research and industry contributions: animal vaccine development and licensing, adjuvant research and development, adjuvant and vaccine marketing, business development, technical consultations... Positions: Director MVP adjuvants, Phibro Animal Health, R&D lead Ceva Animal Health, Research Scientist at University of California, San Diego, Arizona State University, Washington University... Education: Ph.D. pathobiology Utrecht University 2003, MS. veterinary pathology Utrecht University 2000. DVM Addis Ababa University 1995.
Research interests
Adjuvant, Vaccine
Discipline
Bacteriology Clinical trials – efficacy Clinical trials – safety Commercialisation Epidemiology Formulation technology Immunology – B-cells Immunology – T-cells Immunology – innate Pharmacovigilance Regulation Safety evaluation Virology Host species
Camels Cats Cattle Dogs Fish Horses Pigs Poultry Small ruminants Zoonoses Pathogen
Bacteria Bacteria›Clostridia Bacteria›M. hyo Bacteria›Salmonella Parasites›Eimeria Parasites›Trypanosoma Viruses Viruses›Adenovirus Viruses›African horse sickness virus Viruses›African swine fever virus Viruses›Bluetongue virus Viruses›Bovine viral diarrhoea Viruses›Foot-and-mouth disease virus Viruses›Infectious bursal disease virus Viruses›Influenza virus Viruses›Mareks disease virus Viruses›Newcastle disease virus Viruses›Paramyxoviruses Viruses›Parvovirus Viruses›Porcine circovirus Viruses›Porcine reproductive and respiratory syndrome virus Viruses›Rabies virus Viruses›Respiratory syncytial virus Viruses›Rift Valley fever virus Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Commercialisation Correlates of protection – immunomonitoring Marketing Vaccine delivery